Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)

NCT00507065 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

329

Enrollment

INDUSTRY

Sponsor class

Conditions

ADHD

Interventions

DRUG: Mixed salts of a single-entity amphetamine (ADDERALL XR)
DRUG: Placebo

Sponsor

Shire